JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gamm, D. M.
Right arrow Articles by Uhler, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gamm, D. M.
Right arrow Articles by Uhler, M. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 13, Issue of March 31, 1995 pp. 7227-7232
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Isoform-specific Differences in the Potencies of Murine Protein Kinase Inhibitors Are Due to Nonconserved Amino-terminal Residues

(Received for publication, December 7, 1994; and in revised form, January 13, 1995)

David M. Gamm Michael D. Uhler

We provide here a detailed characterization of two isoforms of the protein kinase inhibitor (PKI) protein of cAMP-dependent protein kinase that have dramatically different inhibition constants. Murine PKIbeta1 possesses a 32-fold higher K than murine PKIalpha as determined by Henderson analysis. This finding led to the investigation of C subunitbulletPKI interactions involving nonconserved regions in the carboxyl and amino termini of murine PKIalpha and PKIbeta1. Chimeric cDNAs coding for amino acid sequences from both PKI isoforms were constructed and expressed in bacteria. Surprisingly, exchanging the carboxyl-terminal two-thirds of PKIalpha and PKIbeta1 has relatively little effect on the inhibition constants of the two isoforms. Similarly, introducing amino acid residues corresponding to a beta-turn region of PKIalpha into PKIbeta1 fails to lower PKIbeta1 inhibition constants. However, introducing the amino-terminal alpha-helical region of PKIalpha into PKIbeta1 reduces the K and IC of PKIbeta1 to values identical with full length PKIalpha. Site-directed mutagenesis of specific residues within this region implicates the presence of a tyrosine at position 7 in PKIalpha as a major contributor to its enhanced inhibitory potency. The results of this study suggest that variations in C subunitbulletPKI interactions within an amino-terminal alpha-helix provide a major mechanism for altering the inhibitory properties of PKI isoforms.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. K. Taylor, R. Ahmed, M. Begley, and M. D. Uhler
Autoinhibition and Isoform-specific Dominant Negative Inhibition of the Type II cGMP-dependent Protein Kinase
J. Biol. Chem., September 27, 2002; 277(40): 37242 - 37253.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. P. Collins and M. D. Uhler
Cyclic AMP- and Cyclic GMP-dependent Protein Kinases Differ in Their Regulation of Cyclic AMP Response Element-dependent Gene Transcription
J. Biol. Chem., March 26, 1999; 274(13): 8391 - 8404.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. P. Collins and M. D. Uhler
Characterization of PKIgamma , a Novel Isoform of the Protein Kinase Inhibitor of cAMP-dependent Protein Kinase
J. Biol. Chem., July 18, 1997; 272(29): 18169 - 18178.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Gamm, E. J. Baude, and M. D. Uhler
The Major Catalytic Subunit Isoforms of cAMP-dependent Protein Kinase Have Distinct Biochemical Properties in Vitro and in Vivo
J. Biol. Chem., June 28, 1996; 271(26): 15736 - 15742.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Gamm, S. H. Francis, T. P. Angelotti, J. D. Corbin, and M. D. Uhler
The Type II Isoform of cGMP-dependent Protein Kinase Is Dimeric and Possesses Regulatory and Catalytic Properties Distinct from the Type I Isoforms
J. Biol. Chem., November 10, 1995; 270(45): 27380 - 27388.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. K. Taylor and M. D. Uhler
The Amino-terminal Cyclic Nucleotide Binding Site of the Type II cGMP-dependent Protein Kinase Is Essential for Full Cyclic Nucleotide-dependent Activation
J. Biol. Chem., September 1, 2000; 275(36): 28053 - 28062.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Lum, Z. Hao, D. Gayle, P. Kumar, C. E. Patterson, and M. D. Uhler
Vascular endothelial cells express isoforms of protein kinase A inhibitor
Am J Physiol Cell Physiol, January 1, 2002; 282(1): C59 - C66.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.